Dopavision raised €12M in a funding round in Jul 2021. The company is based in Berlin, Germany. Investors in the round: Boehringer Ingelheim Venture Fund, Novartis Pharmaceuticals, Seventure Partners. Data as of 30 Sept 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
